ArticleJournal of thoracic disease2026

A single-arm, single-center phase II clinical study of concurrent brain radiotherapy combined with tislelizumab and chemotherapy in patients with small-cell lung cancer and brain metastases.

Shuhao Que et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.